Abstract
Much of the emphasis in research on diet and cancer has been focused on the promotion of cancer by dietary fat (Carroll, 1994). However, the lack of support for the fat hypothesis by case-control and cohort studies has led people to question its validity (Land, 1994; Hunter et al., 1996). Epidemiological studies on diet and cancer have provided leads in the search for naturally-occurring anticancer agents (Steinmetz and Potter, 1991a; Block et al., 1992). There is general agreement that plant-based diets, rich in whole grains, legumes, fruits and vegetables reduce the risk of various types of cancer, including breast cancer. A variety of compounds produced by plants have been investigated (Steinmetz and Potter, 1991b; Wattenburg, 1992). These include the flavonoids, which are an integral part of the human diet.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Akiyama, T.; Ishida, J.; Nakagawa, S.; Ogawara, H.; Watanabe, S.; Itoh, N.; Shibuya, M.; Fukami, Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 1987, 262, 5592–5595.
Adlercreutz, H; Honjo, H.; Higashi, A.; Fotsis, T.; Hamalainen, E.; Hasegawa, T.; Okada, H. Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet. Am. J. Clin. Nutr. 1991, 54, 1093–1100.
Bailey, D.G.; Spence, J.D.; Munoz, C.; Arnold, J.M.O. Interaction of citrus juices with felodipine and nifedipine. Lancet 1991, 337, 268–269.
Barnes, S. Effect of genistein on in vitro and in vivo models of cancer. J. Nutr. 1995, 125, 777S–783S.
Block, G.; Patterson, B.; Subar, A. Fruits, vegetables and cancer prevention: A review of the epidemiological evidence. Nutr. Cancer 1992, 18, 1–29.
Boege, F.; Straub, T.; Kehr, A.; Boesenberg, C.; Christiansen, K.; Anderson, A.; Jakob, F.; Kohrle, J. Selected novel flavones inhibit the DNA binding or the DNA religation step of eukaryotic topoisomerase I. J. Biol. Chem. 1996, 271(4), 2262–2270.
Carroll, K.K. Lipids and cancer. In Nutrition and Disease Update. Cancer, Carroll, K.K.; Kritchevsky, D., Eds.; AOCS Press: Champaign, IL, 1994; pp 235–296.
Carroll, K.K.; Guthrie, N.; Nesaretnam, K.; Gapor, A.; Chambers, A.F. Anti-cancer properties of tocotrienols from palm oil. In Nutrition, Lipids, Health, and Disease; Ong, A.S.H.; Niki, E.; Packer, L., Eds.; AOCS Press, Champaign, IL, 1995; pp. 117–121.
Carroll, K.K.; Guthrie, N.; So, F.V.; Chambers, A.F. Anti-cancer properties of flavonoids, with emphasis on citrus flavonoids. In Flavonoids in Health and Disease; Rice-Evans, C.; Packer, L. Eds.; Marcel Dekker, Inc., New York, 1998; pp. 437–446.
Edwards, J.M.; Mori, A.; Nishino, C; Enoki, N.; Tawata, S. Cytotoxicity of plant flavonoids against Hela cells. Phytochemistry 1988, 27, 1017–1020.
Ferriola, P.C.; Cody, V.; Middleton, E. Jr. Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure-activity relationships. Biochem. Pharmacol., 1989, 38, 1617–1624.
Guthrie, N.; Gapor, A.; Chambers, A.F.; Carroll, K.K. Palm oil tocotrienols and plant flavonoids act synergistically with each other and with tamoxifen in inhibiting proliferation and growth of estrogen receptor-negative MDA-MB-435 and-positive MCF-7 human breast cancer cells in culture. Asia Pacific J. Clin. Nutr. 1997a, 6, 41–45.
Guthrie, N.; Gabor, A.; Chambers, A.F.; Carroll, K.K. Inhibition of proliferation of estrogen receptor-negative MDA-MB-435 and-positive MCF-7 human breast cancer cells by palm oil tocotrienols and tamoxifen, alone and in combination. J. Nutr. 1997b, 127, 544S–548S.
Guthrie, N.; Moffatt, M.; Chambers, A.F.; Spence, J.D.; Carroll, K.K. Inhibition of proliferation of human breast cancer cells by naringenin, a flavonoid in grapefruit. Abst. Natl. Forum Breast Cancer, Montreal, PQ, 1993, p 118.
Guthrie, N.; Gapor, A.; Chambers, A.F.; Carroll, K.K. Inhibition of protein kinase C in MDA-MB-435 human breast cancer cells by palm oil tocotrienols. Proc. Can. Fed. Biol. Soc. 1996, 39, Abstract 262.
Hansen, M.B.; Nielsen, S.E.; Berg, K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 1989, 119, 203–210.
Hertog, M.G.L.; Hollman, P.C.H.; Katan, M.B.; Kromhout, D. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in the Netherlands. Nutr. Cancer 1993, 20, 21–29.
Hunter, D.J.; Spiegelman, D.; Adami, H.-O. et al. Cohort studies of fat intake and risk of breast cancer: a pooled analysis. N. Engl. J. Med. 1996, 334, 356–361.
Jordan, V.C. Tamoxifen and tumorigenicity: a predictable concern. J. Natl. Cancer hist. 1995, 87, 623–626.
Jordan, V.C. Long-term tamoxifen treatment for breast cancer. J. Natl. Cancer Inst. 1995, 87, 1176–1177.
Kuhnau, J. The flavonoids. A class of semi-essential food components: Their role in human nutrition. World Rev. Nutr. Diet 1976, 24, 117–191.
Levy, J.; Teuerstein, I.; Marbach, M.; Radian, S.; Sharoni, Y. Tyrosine protein kinase Activity in the DMBA-induced rat mammary tumor:inhibition by quercetin. Biochem. Biophys. Res. Commun. 1984, 123, 1227–1233.
Lund, E. The research tide ebbs for the dietary fat hypothesis in breast cancer. Epidemiology 1994, 5, 387–388.
Messina, M.J.; Persky, V.; Setchell, K.D.R.; Barnes, S. Soy intake and cancer risk:a review of the in vitro and in vivo data. Nutr. Cancer 1994, 21, 113–131.
Messina, M.; Erdman, J.W. Jr., Eds. First international symposium on the role of soy in preventing and treating chronic disease. J. Nutr 1995, 125, 567s–569s.
Middleton, E. Jr.; Kandaswami, C. Potential health-promoting properties of citrus flavonoids. Food Technol. 1994a, 48(11), 115–119.
Middleton, E.; Kandaswami, C. The impact of plant flavonoids on mammalian biology:implications for immunity, inflammation and cancer. In The Flavonoids: Advances in Research Since 1986; Harborne, J.B., Ed.; Chapman and Hall, London, 1994b; pp. 619–652.
Mookerjee, B.K.; Lee, T.-P.; Lippes, H.A.; Middleton, E. Jr. Some effects of flavonoids on lymphocyte proliferative responses. J. Immun. Pharmacol. 1986, 8, 371–392.
Nesaretnam, K.; Guthrie, N.; Chambers, A.F.; Carroll, K.K. Effect of tocotrienols on the growth of a human breast cancer cell line in culture. Lipids 1995, 30, 1139–1143.
Peterson, G.; Barnes, S. Genistein inhibition of the growth of human breast cancer cells: independence from the estrogen receptors and the multi-drug resistance gene. Biochem. Biophys. Res. Commun. 1991, 179, 661–667.
Pelissero, C.; Lenczowski, M.J.; Chinzi, D.; Davail-Cuisset, B.; Sumpter, J.P.; Fostier, A. Effects of flavonoids on aromatase activity, an in vitro study. J. Steroid Biochem. Mol. Biol. 1996, 57, 215–223.
Raffauf, R.F.; Le Quesne, P.W. Antineoplastic activity and cytotoxicity of flavones, soflavones, and flavonones. J. Nat. Prod. 1919, 42, 85–91.
Ramanathan, R.; Tan, C.H.; Das, N.P. Cytotoxic effect of plant polyphenols and fat-soluble vitamins on malignant human cultured cells. Cancer Lett. 1992, 62, 217–224.
Sharoni, Y.; Teuerstein, I.; Levy, J. Phosphoinositide phosphorylation precedes growth in rat mammary tumors. Biochem. Biophys. Res. Commun. 1998, 134, 876–882.
Singhal, R.L.; Yeh, Y.A.; Prajda, N.; Olah, E.; Sledge, G.W. Jr.; Weber, G. Quercetin down regulates signal transduction in human breast carcinoma. Biochem. Biophys. Res. Commun. 1995, 208, 425–431.
So, F.V.; Guthrie, N.; Chambers, A.F.; Moussa, M.; Carroll, K.K. Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices. Nutr. Cancer 1996a, 26, 167–181.
So, F.V. Dietary flavonoids and breast cancer: in vitro, in vivo and mechanism studies. M.Sc. Thesis, 1996b; The Univ. of Western Ontario, London, Ontario.
So, F.V.; Guthrie, N.; Chambers, A.F.; Carroll, K.K. Inhibition of proliferation of estrogen receptor-positive MCF-7 human breast cancer cells by flavonoids in the presence and absence of excess estrogen. Cancer Lett. 1991,112, 127–133.
Steinmetz, K.A.; Potter, J.D. Vegetables, fruit, and cancer. I. Epidemiology. Cancer Causes Control 1991a, 2, 325–357.
Steinmetz, K.A.; Potter, J.D. Vegetables, fruit, and cancer. II. Mechanisms. Cancer Causes Control 1991b, 2, 427–442.
Verma, A.K.; Johnson, J.A.; Gould, M.N.; Tanner, M.A. Inhibition of 7,12-dimethylbenz[a]anthracene-and n-nitrosomethylurea-induced rat mammary cancer by the dietary flavonol quercetin. Cancer Res. 1988, 48, 5754–5758.
Wattenburg, L.W. Inhibition of carcinogenesis by minor dietary constituents. Cancer Res. 1992, 52, 2085s–2091s.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Guthrie, N., Carroll, K.K. (1998). Inhibition of Mammary Cancer by Citrus Flavonoids. In: Manthey, J.A., Buslig, B.S. (eds) Flavonoids in the Living System. Advances in Experimental Medicine and Biology, vol 439. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5335-9_16
Download citation
DOI: https://doi.org/10.1007/978-1-4615-5335-9_16
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7434-3
Online ISBN: 978-1-4615-5335-9
eBook Packages: Springer Book Archive